Radiological assessment of hip disease in children with cerebral palsy: development of a core measurement set

Prince J S Joseph1, Mohammed Khattak1,2, Sundas T Masudi3

  • 1University of Liverpool, Liverpool, UK.

Bone & Joint Open
|November 1, 2023
PubMed

Insights

A core measurement set for hip surveillance in children with cerebral palsy (CP) was developed. This standardized approach aims to improve consistency in radiological outcomes for better clinical care and research.

Area of Science:

  • Pediatric Orthopedics
  • Rehabilitation Medicine
  • Medical Imaging

Background:

  • Hip disease is a common complication in children with cerebral palsy (CP), significantly impacting their quality of life and functional abilities.
  • Current radiological surveillance programs for hip disease in CP lack standardized outcome measures, hindering comparative analysis and consistent treatment strategies.

Purpose of the Study:

  • To identify and establish a core measurement set (CMS) for radiological assessment of hip disease in children with CP.
  • To promote uniformity in clinical practice, research studies, and surveillance programs for improved patient outcomes.

Main Methods:

  • A systematic review identified radiological measurements used in studies of hip outcomes in children with CP.
  • A two-round Delphi study involving orthopedic surgeons and physiotherapists was conducted to rate the importance of identified measurements.
  • A consensus meeting finalized the core measurement set.

Main Results:

  • A systematic review identified 14 distinct radiological measurements, with Reimer's migration percentage being most common.
  • The Delphi process and consensus meeting resulted in the selection of two key measurements: Reimer's migration percentage and femoral head-shaft angle.
  • These two measurements form the core measurement set for hip surveillance in children with CP.

Conclusions:

  • The developed CMS provides a standardized minimum set of measurements for hip surveillance in children with CP.
  • This standardization is expected to enhance consistency across surveillance programs and facilitate the development of automated analysis tools, such as AI systems.
  • Adoption of this core set will enable more reliable comparisons between studies and support future meta-analyses, ultimately improving the management of hip disease in this population.
Abstract